PT  - JOURNAL ARTICLE
AU  - Beckmann, Noam D.
AU  - Comella, Phillip H.
AU  - Cheng, Esther
AU  - Lepow, Lauren
AU  - Beckmann, Aviva G.
AU  - Mouskas, Konstantinos
AU  - Simons, Nicole W.
AU  - Hoffman, Gabriel E.
AU  - Francoeur, Nancy J.
AU  - Valle, Diane Marie Del
AU  - Kang, Gurpawan
AU  - Moya, Emily
AU  - Wilkins, Lillian
AU  - Berichel, Jessica Le
AU  - Chang, Christie
AU  - Marvin, Robert
AU  - Calorossi, Sharlene
AU  - Lansky, Alona
AU  - Walker, Laura
AU  - Yi, Nancy
AU  - Yu, Alex
AU  - Hartnett, Matthew
AU  - Eaton, Melody
AU  - Hatem, Sandra
AU  - Jamal, Hajra
AU  - Akyatan, Alara
AU  - Tabachnikova, Alexandra
AU  - Liharska, Lora E.
AU  - Cotter, Liam
AU  - Fennessey, Brian
AU  - Vaid, Akhil
AU  - Barturen, Guillermo
AU  - Tyler, Scott R.
AU  - Shah, Hardik
AU  - Wang, Ying-chih
AU  - Sridhar, Shwetha Hara
AU  - Soto, Juan
AU  - Bose, Swaroop
AU  - Madrid, Kent
AU  - Ellis, Ethan
AU  - Merzier, Elyze
AU  - Vlachos, Konstantinos
AU  - Fishman, Nataly
AU  - Tin, Manying
AU  - Smith, Melissa
AU  - Xie, Hui
AU  - Patel, Manishkumar
AU  - Argueta, Kimberly
AU  - Harris, Jocelyn
AU  - Karekar, Neha
AU  - Batchelor, Craig
AU  - Lacunza, Jose
AU  - Yishak, Mahlet
AU  - Tuballes, Kevin
AU  - Scott, Leisha
AU  - Kumar, Arvind
AU  - Jaladanki, Suraj
AU  - Thompson, Ryan
AU  - Clark, Evan
AU  - Losic, Bojan
AU  - ,
AU  - Zhu, Jun
AU  - Wang, Wenhui
AU  - Kasarskis, Andrew
AU  - Glicksberg, Benjamin S.
AU  - Nadkarni, Girish
AU  - Bogunovic, Dusan
AU  - Elaiho, Cordelia
AU  - Gangadharan, Sandeep
AU  - Ofori-Amanfo, George
AU  - Alesso-Carra, Kasey
AU  - Onel, Kenan
AU  - Wilson, Karen M.
AU  - Argmann, Carmen
AU  - Alarcón-Riquelme, Marta E.
AU  - Marron, Thomas U.
AU  - Rahman, Adeeb
AU  - Kim-Schulze, Seunghee
AU  - Gnjatic, Sacha
AU  - Gelb, Bruce D.
AU  - Merad, Miriam
AU  - Sebra, Robert
AU  - Schadt, Eric E.
AU  - Charney, Alexander W.
TI  - Cytotoxic lymphocytes are dysregulated in multisystem inflammatory syndrome in children
AID  - 10.1101/2020.08.29.20182899
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.29.20182899
4099  - http://medrxiv.org/content/early/2020/09/02/2020.08.29.20182899.short
4100  - http://medrxiv.org/content/early/2020/09/02/2020.08.29.20182899.full
AB  - Multisystem inflammatory syndrome in children (MIS-C) presents with fever, inflammation and multiple organ involvement in individuals under 21 years following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. To identify genes, pathways and cell types driving MIS-C, we sequenced the blood transcriptomes of MIS-C cases, pediatric cases of coronavirus disease 2019, and healthy controls. We define a MIS-C transcriptional signature partially shared with the transcriptional response to SARS-CoV-2 infection and with the signature of Kawasaki disease, a clinically similar condition. By projecting the MIS-C signature onto a co-expression network, we identified disease gene modules and found genes downregulated in MIS-C clustered in a module enriched for the transcriptional signatures of exhausted CD8+ T-cells and CD56dimCD57+ NK cells. Bayesian network analyses revealed nine key regulators of this module, including TBX21, a central coordinator of exhausted CD8+ T-cell differentiation. Together, these findings suggest dysregulated cytotoxic lymphocyte response to SARS-Cov-2 infection in MIS-C.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Icahn School of Medicine at Mount Sinai.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of the Icahn School of Medicine at Mount SinaiAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request following publication in a peer-reviewed journal